Jump to content

Reparagen

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Josve05a (talk | contribs) at 19:12, 9 June 2024 (added orphan tag). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Reparagen is a joint health product that scientists at Albany Medical College ran clinical trials on to test the theory that the combination of Uncaria guianensis and Lepidium meyenii can turn on Insulin-like growth factor[1][2]

References

[edit]
  1. ^ "Gene Therapy Research Switches Off Joint Inflammation; Switches On Genetic Process Of Joint Repair".
  2. ^ Mehta, Komal; Jayesh Gala; Surendra Bhasale; Sattayasheel Naik; Millind Modak; Harshad Thakur; Nivedita Deo; Mark JS Miller (October 31, 2007). "Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]". BMC Complementary and Alternative Medicine. 34. 7: 34. doi:10.1186/1472-6882-7-34. PMC 2131759. PMID 17974032.


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Reparagen&oldid=1228156365"